CheMatech entered an agreement with Bioacts for the distribution of its unique fluorescent technologies, offers Flamma series with full spectrum for labeling antibodies, proteins, peptides and other biomolecules.

We are very glad to announce that we are now the distributor of preclinical MRI probes developped by GUERBET. We offer a portfolio of very efficient Gd and Fe based MRI probes for preclinical research.

Preclinical imaging is a very efficient tool for the evaluation of new treatment and especially in oncology. CheMatech has access to Pharm’image preclinical imaging plateform and can assist you for pharmaco-imaging studies.

CheMatech is the european leader in the design, the synthesis and the supply of chelating agents, such as DOTA derivatives, precursors of MRI contrast agents and PET and SPECT tracers.
CheMatech offers a wide range of chelators from milligrams to hundred grams scale. CheMatech also realizes custom syntheses of new chelating agents and can take in charge the development of it’s client’s compounds.

CheMatech can help in the synthesis of a targeted molecule from the conception to the preparation in bulk quantities. CheMatech also provides a cGMP service for the production of starting materials and intermediates